Get started
Author

Hao Yan

Observed name: Yan, Hao
ORCID: 0000-0003-1468-6165
Observed ORCIDs: 0000-0003-1468-6165, 0000-0001-9905-9173
OpenAlex ID: A5046375343
Per- and poly-fluoroalkyl substances (PFAS) accelerate biological aging mediated by increased C-reactive protein
2024 · Zongxi Zhao, Jiayan Zhou, et al. · Journal of Hazardous Materials · 18
Resveratrol ameliorates ionizing irradiation-induced long-term immunosuppression in mice
2017 · Heng Zhang, Hao Yan, et al. · International Journal of Radiation Biology · 17
Erythropoietin receptor on cDC1s dictates immune tolerance
2025 · Xiangyue Zhang, Christopher S. McGinnis, et al. · Nature · 15
Single-cell transcriptomic profiling reveals diversity in human iNKT cells across hematologic tissues
2025 · Reyka G. Jayasinghe, Derek Hollingsworth, et al. · Cell Reports · 14
CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets
2024 · Xiangni Wu, Pin-I Chen, et al. · Frontiers in Immunology · 13
Primary oocytes with cellular senescence features are involved in ovarian aging in mice
2024 · Hao Yan, Edgar Andres Diaz Miranda, et al. · Scientific Reports · 13
Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026 · Sarah Brooke Sirota, Rose Grace Bender, et al. · The Lancet Neurology · 7
invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies
2024 · Chaiyaporn Boonchalermvichian, Hao Yan, et al. · Frontiers in Transplantation · 7
Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026 · Avina Vongpradith, Regina-Mae Villanueva Dominguez, et al. · The Lancet Infectious Diseases · 6
Extracellular release of damaged mitochondria induced by prehematopoietic stem cell transplant conditioning exacerbates GVHD
2024 · Vijith Vijayan, Hao Yan, et al. · Blood Advances · 6
Global, regional, and national levels and trends in maternal mortality, progress towards the Sustainable Development Goals, and mortality from COVID-19 infection in pregnant women, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026 · Jennifer Faith, Ira Martopullo, et al. · The Lancet Obstetrics Gynaecology & Women s Health · 3
PDF
Anterior Uveitis in an HLA-B27 Positive Patient Following Influenza Vaccination
2026 · Chenjie Pan, Anania Woldetensaye, et al. · International Medical Case Reports Journal · 1
PDF
CD117 CAR-iNKT Cells As a Safe and Effective Off-the-Shelf Allogeneic Cell Therapy for AML
2025 · Hao Yan, Chaiyaporn Boonchalermvichian, et al. · Transplantation and Cellular Therapy · 1
Engineered Invariant Natural Killer T Cells (iNKT cells) Targeting CD 117 As a Novel Treatment for Acute Myeloid Leukemia.
2025 · Chaiyaporn Boonchalermvichian, Hao Yan, et al. · Transplantation and Cellular Therapy · 1
Single cell resolution analysis of multi-tissue derived human iNKT cells reveals novel transcriptional paradigms
2024 · Reyka G. Jayasinghe, Derek Hollingsworth, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Author Correction: Erythropoietin receptor on cDC1s dictates immune tolerance
2026 · Xiangyue Zhang, Christopher S. McGinnis, et al. · Nature
PDF
Multimodal immunotherapy for high-risk acute myeloid leukemia and myelodysplastic syndrome.
2026 · Parveen Shiraz, Carlos Jose Rodriguez Santiago, et al. · Journal of Clinical Oncology
Selective Immune Silencing by Targeted TGF-β Mimics
2026 · Qinli Sun, Masato Ogishi, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Targeting CD117 with engineered invariant natural killer T cells (iNKT Cells) as a novel approach for acute myeloid leukemia treatment
2025 · Chaiyaporn Boonchalermvichian, Hao Yan, et al. · Blood
Inhibition of DRP1–FIS1–Mediated mitochondrial fission as a novel strategy to prevent gvhd
2025 · Hao Yan, Vijith Vijayan, et al. · Blood
PDF
Off-the-shelf CD117 CAR-iNKT cells as a safe and effective allogeneic immunotherapy targeting AML and its immunosuppressive microenvironment
2025 · Hao Yan, Chaiyaporn Boonchalermvichian, et al. · Blood
Secondary lymphoid organ endothelial cells prime alloreactive CD4 + T cells to trigger acute graft-versus-host disease
2025 · Haroon Shaikh, Pia Wittmann, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Host-Derived Immunoregulatory Invariant Natural Killer T Cell Subset, iNKT2 Is Instrumental for Prevention of Acute Graft Versus Host Disease in Mice
2025 · Biki Gupta, Jeanette Baker, et al. · Transplantation and Cellular Therapy
Erythropoietin Promotes GvHD Prevention through Type 1 Conventional Dendritic Cells
2024 · Hao Yan, Xiangyue Zhang, et al. · Blood
PDF
Novel Subsets of Human Invariant Natural Killer T Cells, Including a Temra-like CD4−CD8− Population, Revealed through Single Cell RNA-Sequencing
2024 · Dr. Melissa Mavers, Derek Hollingsworth, et al. · Transplantation and Cellular Therapy
Works count: 32
Citation count: 123
H-index: 7
I10-index: 6
Year
Topic
Type